3M Company is a diversified global technology and manufacturing company incorporated in Delaware in 1929, with operations dating to 1902. It sells products through three reportable segments: Safety and Industrial, Transportation and Electronics, and Consumer. Its portfolio includes abrasives, adhesives and tapes, personal safety, electrical materials, roofing granules, automotive and aerospace solutions, electronics materials, semiconductor and data-center solutions, graphic films, home cleaning, office products, automotive appearance, and consumer health products. 3M sells directly and through distributors, wholesalers, retailers, jobbers, and dealers worldwide. At December 31, 2025, 3M employed approximately 60,500 people; approximately 56% of 2025 revenue came from outside the United States. The company completed the spin-off of its former Health Care business, Solventum, on April 1, 2024, and completed its exit from PFAS manufacturing at the end of 2025.
Prepared by: Md Kollol Hossain, CEO, CapitalinsightBD
Contact: info@capitalinsightbd.com
Primary basis: 3M Form 10-K for FY2025 and Form 10-Q for Q3 2026 (quarter ended September 30, 2026).
Secondary basis: Capital Insight BD “S&P 500 Stock Analysis Master Dashboard” for MMM, analysis period 2026-01-01 → 2026-10-23 (market data, valuation multiples, composite scores, sector comparison, ownership). Dashboard market/valuation metrics are sourced from YFinance and related fundamental/market feeds as noted in Section 17.
Important: The 10-K is FY2025, not FY2026. The attached 10-Q is Q3/9M 2026. All figures are USD million unless stated; large figures are also shown in USD billion. Δ% is author-calculated from reported figures. “n/m” = not meaningful. “NA” = not available in the attached filings.
Source: 10-K pp. 4–6, 10, 21; 10-K p. 50.
2. Executive Summary
3M’s FY2025 results show modest revenue growth but lower GAAP profitability versus FY2024, driven by litigation/PFAS-exit costs, divestiture charges, transformation costs, pension settlement comparison, and tax effects. FY2025 revenue was $24.948B**, up **1.5%**; operating income was **$4.629B, down 4.0%; net income attributable to 3M was $3.250B**, down **22.1%**; diluted EPS was **$6.00, down 20.5%. FY2025 GAAP operating margin was 18.6% versus 19.6% in FY2024.
The 9M 2026 picture improved: revenue $19.114B**, up **1.6%**; operating income **$3.939B, up 2.8%; net income attributable to 3M $2.959B**, up **10.7%**; diluted EPS **$5.63, up 14.2%. However, leverage remains elevated: total debt at Sep 30, 2026 was $14.997B** versus total equity of **$4.169B, and PFAS/CAE/asbestos liabilities remain the central risk. PwC issued an unqualified opinion on the FY2025 financial statements and internal control over financial reporting; no going-concern qualification or audit objection is stated.
Market snapshot (2026-10-23): price $173.46**; market cap **$89.46B; period return 7.19% vs S&P 500 11.16%; trailing PE 25.89x; forward PE 17.51x; PEG 1.57; composite score 48.2/100. The market is pricing MMM at a discount to the Industrials sector PE (25.89x vs 32.97x, i.e. -21.47%), but at a premium on PB (21.72x vs 8.64x).
Source: 10-K pp. 21–23, 37–40, 42, 44; 10-Q pp. 3, 5, 6, 19–41; Capital Insight BD Dashboard (2026-10-23).
Key FY2025 / 9M2026 figures
| Metric | FY2025 | FY2024 | Δ% | 9M 2026 | 9M 2025 | Δ% |
|---|---|---|---|---|---|---|
| Net sales | $24.948B | $24.575B | +1.5% | $19.114B | $18.815B | +1.6% |
| Gross profit | $9.957B | $10.128B | -1.7% | $7.922B | $7.899B | +0.3% |
| Operating income | $4.629B | $4.822B | -4.0% | $3.939B | $3.833B | +2.8% |
| Net income attributable to 3M | $3.250B | $4.173B | -22.1% | $2.959B | $2.673B | +10.7% |
| Diluted EPS | $6.00 | $7.55 | -20.5% | $5.63 | $4.93 | +14.2% |
| Total assets | $37.733B | $39.868B | -5.4% | $39.526B | NA* | NA* |
| Total equity | $4.747B | $3.894B | +21.9% | $4.169B | NA* | NA* |
| Cash from operations | $2.306B | $1.819B | +26.8% | $2.046B | $0.723B | +183.0% |
*9M25 balance sheet is not included in the supplied 10-Q comparative balance sheet; only Dec 31, 2025 is presented.
Source: 10-K p. 40, p. 42, p. 44; 10-Q p. 3, p. 5, p. 6.
3. Comparative Financial Statements — Item-by-Item YoY
3.1 Income Statement, FY2025 vs FY2024
| Line item | FY2025 | FY2024 | Change | Δ% |
|---|---|---|---|---|
| Net sales | $24,948 | $24,575 | +$373 | +1.5% |
| Cost of sales | $14,991 | $14,447 | +$544 | +3.8% |
| SG&A | $3,997 | $4,221 | -$224 | -5.3% |
| R&D | $1,169 | $1,085 | +$84 | +7.7% |
| Loss on business divestitures | $162 | $0 | +$162 | n/m |
| Total operating expenses | $20,319 | $19,753 | +$566 | +2.9% |
| Operating income | $4,629 | $4,822 | -$193 | -4.0% |
| Other expense, net | $416 | $3 | +$413 | n/m |
| Income before taxes | $4,213 | $4,819 | -$606 | -12.6% |
| Provision for income taxes | $1,003 | $804 | +$199 | +24.8% |
| Income from continuing operations of consolidated group | $3,210 | $4,015 | -$805 | -20.0% |
| Income from unconsolidated subsidiaries, net of taxes | $52 | $9 | +$43 | +477.8% |
| Net income including NCI | $3,262 | $4,024 | -$762 | -18.9% |
| Less: NCI | $12 | $15 | -$3 | -20.0% |
| Net income from continuing ops attributable to 3M | $3,250 | $4,009 | -$759 | -18.9% |
| Discontinued operations, net of taxes | $0 | $164 | -$164 | -100.0% |
| Net income attributable to 3M | $3,250 | $4,173 | -$923 | -22.1% |
| Diluted EPS | $6.00 | $7.55 | -$1.55 | -20.5% |
| Diluted shares | 541.3M | 552.4M | -11.1M | -2.0% |
3.2 Balance Sheet, Dec 31, 2025 vs Dec 31, 2024
| Line item | Dec 31, 2025 | Dec 31, 2024 | Change | Δ% |
|---|---|---|---|---|
| Cash and cash equivalents | $5,235 | $5,600 | -$365 | -6.5% |
| Marketable securities | $698 | $2,128 | -$1,430 | -67.2% |
| Accounts receivable, net | $3,533 | $3,194 | +$339 | +10.6% |
| Inventories | $3,661 | $3,698 | -$37 | -1.0% |
| Prepaids | $391 | $493 | -$102 | -20.7% |
| Assets held for sale | $46 | $0 | +$46 | n/m |
| Other current assets | $2,823 | $771 | +$2,052 | +266.2% |
| Total current assets | $16,387 | $15,884 | +$503 | +3.2% |
| PP&E, net | $7,101 | $7,388 | -$287 | -3.9% |
| Goodwill | $6,419 | $6,281 | +$138 | +2.2% |
| Intangible assets, net | $1,103 | $1,210 | -$107 | -8.8% |
| Other assets | $6,723 | $9,105 | -$2,382 | -26.2% |
| Total assets | $37,733 / $37.733B | $39,868 | -$2,135 | -5.4% |
| Short-term borrowings/current LTD | $1,670 | $1,919 | -$249 | -13.0% |
| Accounts payable | $2,702 | $2,660 | +$42 | +1.6% |
| Accrued payroll | $718 | $712 | +$6 | +0.8% |
| Liabilities held for sale | $55 | $0 | +$55 | n/m |
| Other current liabilities | $4,450 | $5,965 | -$1,515 | -25.4% |
| Total current liabilities | $9,595 | $11,256 | -$1,661 | -14.8% |
| Long-term debt | $10,932 | $11,125 | -$193 | -1.7% |
| Pension/postretirement | $1,631 | $1,813 | -$182 | -10.0% |
| Other liabilities | $10,828 | $11,780 | -$952 | -8.1% |
| Total liabilities | $32,986 / $32.986B | $35,974 | -$2,988 | -8.3% |
| Total 3M shareholders’ equity | $4,702 / $4.702B | $3,842 | +$860 | +22.4% |
| Noncontrolling interest | $45 | $52 | -$7 | -13.5% |
| Total equity | $4,747 / $4.747B | $3,894 | +$853 | +21.9% |
| Total liabilities and equity | $37,733 / $37.733B | $39,868 | -$2,135 | -5.4% |
3.3 Cash Flow Statement, FY2025 vs FY2024
| Line item | FY2025 | FY2024 | Change | Δ% |
|---|---|---|---|---|
| Net income including NCI | $3,262 | $4,188 | -$926 | -22.1% |
| D&A | $1,308 | $1,363 | -$55 | -4.0% |
| Pension contributions | -$145 | -$154 | +$9 | -5.8% |
| Pension expense | $272 | $1,035 | -$763 | -73.7% |
| Stock-based compensation | $225 | $289 | -$64 | -22.1% |
| Loss on divestitures | $162 | $0 | +$162 | n/m |
| Deferred income taxes | $418 | $321 | +$97 | +30.2% |
| Accounts receivable | -$211 | $114 | -$325 | n/m |
| Inventories | $139 | $41 | +$98 | +239.0% |
| Accounts payable | $214 | $61 | +$153 | +250.8% |
| Other, net | -$3,145 | -$5,424 | +$2,279 | n/m |
| CFO | $2,306 / $2.306B | $1,819 | +$487 | +26.8% |
| Capex | -$910 | -$1,181 | +$271 | -22.9% |
| Purchases of marketable securities/investments | -$1,305 | -$4,153 | +$2,848 | n/m |
| Proceeds from maturities/sales | $3,468 | $2,074 | +$1,394 | +67.2% |
| CFI | $1,350 | -$3,206 | +$4,556 | n/m |
| Repayment of debt | -$1,815 | -$2,656 | +$841 | -31.7% |
| Proceeds from debt | $1,099 | $8,367 | -$7,268 | -86.9% |
| Treasury stock purchases | -$3,251 | -$1,801 | -$1,450 | +80.5% |
| Proceeds from treasury stock issuance | $1,562 | $922 | +$640 | +69.4% |
| Dividends paid | -$1,562 | -$1,982 | +$420 | -21.2% |
| Cash transferred to Solventum | $0 | -$621 | +$621 | n/m |
| CFF | -$4,016 | $1,098 | -$5,114 | n/m |
| FX effect | $41 | -$44 | +$85 | n/m |
| Net change in cash | -$365 | -$333 | -$32 | n/m |
| Cash at end | $5,235 / $5.235B | $5,600 | -$365 | -6.5% |
4. Ratio Analysis — Grouped, with Change
Note: Ratios calculated from reported statements. For turnover ratios, ending balances are used for FY2025/FY2024 comparability; 9M 2026 uses 273 days and average balances where possible. “USA industry average” is NA because the attached filings do not provide it. Market-based ratios are sourced from the Capital Insight BD dashboard (YFinance-derived), as noted in Section 17.
| Group | Ratio | FY2025 | FY2024 | Change | 9M/Q3 2026 |
|---|---|---|---|---|---|
| Liquidity | Current ratio | 1.71x | 1.41x | +0.30x | 1.41x |
| Quick ratio | 0.99x | 0.97x | +0.02x | 0.78x | |
| Cash ratio | 0.62x | 0.69x | -0.07x | 0.43x | |
| Working capital | $6,792M | $4,628M | +$2,164M | $4,846M | |
| Profitability | Gross margin | 39.9% | 41.2% | -1.3 pp | 41.5% |
| Operating margin | 18.6% | 19.6% | -1.0 pp | 20.6% | |
| Net margin (attributable) | 13.0% | 17.0% | -4.0 pp | 15.5% | |
| EBITDA margin | 23.8% | 25.2% | -1.4 pp | 32.2% TTM* | |
| ROA (avg assets) | 8.4% | NA | NA | NA | |
| ROE (avg 3M equity) | 76.1% | NA | NA | NA | |
| Effective tax rate | 23.8% | 16.7% | +7.1 pp | 18.1% | |
| Efficiency | Inventory days (DIO) | 89.1 days | 93.4 days | -4.3 days | 94.4 days |
| Receivable days (DSO) | 51.7 days | 47.4 days | +4.3 days | 54.6 days | |
| Payable days (DPO) | 65.8 days | 67.2 days | -1.4 days | 70.0 days | |
| Cash conversion cycle | 75.0 days | 73.7 days | +1.3 days | 79.0 days | |
| Solvency | Total debt / total equity | 2.65x | 3.35x | -0.70x | 3.60x |
| Net debt / EBITDA | 1.12x | 0.86x | +0.26x | 1.60x TTM | |
| Interest coverage (EBIT/interest) | 4.89x | 4.05x | +0.84x | 5.54x TTM | |
| Per-share | Diluted EPS | $6.00 | $7.55 | -20.5% | $5.63 |
| NAVPS (3M equity / shares) | $8.87 | NA | NA | $7.99 | |
| CFO per diluted share | $4.26 | $3.29 | +29.5% | $3.89 | |
| Valuation (market) | PE (trailing) | — | — | — | 25.89x |
| Forward PE | — | — | — | 17.51x | |
| PEG | — | — | — | 1.57 | |
| PB | — | — | — | 21.72x | |
| PS | — | — | — | 3.54x | |
| EV/EBITDA | — | — | — | 15.21x | |
| EV/Revenue | — | — | — | 3.92x |
*TTM EBITDA = FY2025 operating income − 9M25 operating income + 9M26 operating income + TTM D&A; TTM D&A = FY2025 D&A − 9M25 D&A + 9M26 D&A.
Source: 10-K pp. 40, 42, 44; 10-Q pp. 3, 5, 6, 14; Capital Insight BD Dashboard (2026-10-23).
Ratio commentary
- Liquidity: FY2025 current ratio improved to 1.71x from 1.41x, but 9M 2026 fell back to 1.41x as current liabilities rose, including current PFAS settlement and debt. Quick ratio at 9M 2026 is 0.78x, weaker than FY2025.
- Profitability: Gross and operating margins compressed in FY2025 due to PFAS/litigation, divestiture charges, tariffs, and PFAS-exit dis-synergies. 9M 2026 margins improved on lower litigation costs and insurance recoveries.
- Efficiency: Receivable days rose to 54.6 days in 9M 2026 from 51.7 days FY2025; inventory days rose to 94.4 days. CCC widened to 79.0 days.
- Solvency: Debt/equity is high because equity is small after buybacks and charges. Net debt/EBITDA remains moderate at ~1.6x TTM, and interest coverage is ~5.5x.
- Market valuation: Trailing PE 25.89x is below the Industrials sector average of 32.97x (-21.47%), and the PE percentile is 34.3% of its own history (hist. avg. 27.52x). Forward PE 17.51x implies the market expects meaningful EPS recovery. PB 21.72x is far above sector 8.64x, reflecting 3M’s low book equity after buybacks and charges.
- Industry position: U.S. industry-average operating ratios are not in the attached filings; sector comparison in Section 14 uses the dashboard’s Industrials peer set (83 peers).
5. Opportunities and Threats for New Shareholders
Opportunities
| Opportunity | Evidence | Investor relevance | Source |
|---|---|---|---|
| Portfolio simplification | Solventum spin completed Apr 1, 2024; PFAS manufacturing exit completed end-2025 | Cleaner but smaller company; management focus | 10-K pp. 21, 50; 10-Q p.21 |
| Safety & Industrial growth | FY2025 segment sales +3.9%; 9M26 +8.0%; Q3 2026 +9.1% | Electrical, adhesives, personal safety, fire safety | 10-K p.25; 10-Q p.48 |
| Data center / semiconductor / aerospace | 9M26 Transportation & Electronics growth driven by semiconductor, aerospace, data center | Higher-growth electronics exposure | 10-Q p.48 |
| Madison Fire & Rescue acquisition | $1.9B acquisition; venture with Bain; 3M 50.1% voting; fire rescue portfolio | New fire-safety platform | 10-Q pp. 8–9 |
| Productivity and transformation | Transformation program; procurement/logistics savings | Margin recovery potential | 10-K p.21; 10-Q p.10 |
| Strong cash generation | FY2025 CFO $2.306B; 9M26 CFO $2.046B, +183% YoY | Funds dividends, buybacks, litigation | 10-K p.44; 10-Q p.6 |
| Dividend and buyback | Dividend $0.78/qtr in 2026; $7.5B buyback authorization | Shareholder returns | 10-Q p.54, p.56 |
| Solventum stake | ~15% stake; fair value $2.3B at Sep 30, 2026 | Potential liquidity source | 10-Q p.11, p.53 |
Threats
| Threat | Evidence | Investor relevance | Source |
|---|---|---|---|
| PFAS litigation/regulation | PWS settlement $10.5–$12.5B; AFFF MDL ~15,250 cases; state AG suits; environmental accrual $7.5B | Large cash outflows; EPS volatility | 10-K pp. 73–95; 10-Q pp. 19–38 |
| CAE earplug settlement | Up to $6.0B 2023–2029; accrual $1.1B at Sep 30, 2026 | Fixed payment obligation | 10-K pp. 94–95; 10-Q p.40 |
| Respirator/asbestos | 4,200 claimants; accrual $439M; WV litigation | Tail risk | 10-Q pp. 38–40 |
| Leverage / low equity | Total debt $14.997B; equity $4.169B; D/E 3.60x | Refinancing and rating risk | 10-Q p.5; 10-K p.33 |
| Tariffs / FX / geopolitics | 56% non-US revenue; tariff and trade risk | Margin volatility | 10-K p.10; 10-Q p.46 |
| PFAS exit dis-synergies | Cost dis-synergies in segments | Margin drag | 10-K p.26; 10-Q p.48 |
| Pension assumptions | 98% funded; discount rate 5.41%; return 8.0% | Contribution/expense risk | 10-K p.24, p.32 |
| Cyber/AI/ERP risk | ERP implementation; AI risk factors | Operational disruption | 10-K p.15–16 |
| Solventum stake volatility | Mark-to-market in other expense | EPS noise | 10-Q p.11 |
| Relative underperformance | Stock 7.19% vs S&P 500 11.16% in 2026 YTD; correlation 0.336 | Weak beta/alpha in 2026 | Dashboard (2026-10-23) |
6. Audit Objections / Observations
- PwC opinion: Unqualified opinion on the consolidated financial statements and effective internal control over financial reporting as of Dec 31, 2025.
Source: 10-K p. 38. - Management assessment: ICFR effective as of Dec 31, 2025.
Source: 10-K p. 37; p. 103. - Audit objections/observations: No audit objection, qualified opinion, adverse opinion, or material weakness is stated in the readable portions of the attached 10-K. The Critical Audit Matters section on 10-K p. 39 is garbled in the supplied text, so CAM details cannot be reliably extracted.
- Going concern: No going-concern qualification or disclosure is present.
- Audit-risk areas disclosed: legal contingencies (PFAS/CAE/asbestos), income-tax uncertainties (IRS examinations 2021–2023; gross UTB $516M; interest/penalties $195M), goodwill ($6.4B, no impairment), pension assumptions, and environmental accruals. These are judgment areas that could affect future earnings.
Source: 10-K pp. 31–33, 38–39, 56–58, 73–95.
7. Litigation — Current Position and What-If EPS Impact
Current position summary
| Matter | Current position / accrual | Potential earnings impact |
|---|---|---|
| PFAS / PWS Settlement | PWS settlement $10.5–$12.5B, payments 2024–2036; pre-tax charge $10.3B in Q2 2023. Environmental liabilities $7.5B at Sep 30, 2026 ($2.8B current, $4.7B other). AFFF MDL ~15,250 cases as of Oct 1, 2026. | Cash payments and interest accretion; additional claims possible. $1B pre-tax charge ≈ $1.51 EPS impact at 21% tax and 522.6M diluted shares. |
| New Jersey PFAS settlement | Up to $450M; $281M pre-tax charge in Q2 2025; final approval Aug 2026, appeal period lapsed. | Largely accrued; cash payments 2026–2050. |
| CAE earplugs | Up to $6.0B 2023–2029; accrual $1.1B at Sep 30, 2026 ($0.6B current, $0.5B other); >99% participation. | Fixed schedule; $1B pre-tax ≈ $1.51 EPS. |
| Respirator/asbestos | Non-Aearo accrual $439M; Aearo $56M; ~4,200 claimants. WV litigation pending; no liability recorded for WV. | Tail risk; $500M pre-tax ≈ $0.76 EPS. |
| Watson Grinding | Multiple Texas trials; some juries found partial liability; no accrual because loss not probable/estimable. | Unquantified; adverse outcome could be material. |
| Belgium / Netherlands / Canada / Australia | PFAS claims and regulatory actions; Belgium remediation agreement €571M; 22 Belgian civil actions; Dutch, Canadian, Australian claims. | Additional remediation/legal costs possible. |
Illustrative what-if EPS impact
Assumptions: 21% tax rate; diluted shares 522.6M; not a company estimate.
| Additional pre-tax charge | After-tax impact | EPS impact |
|---|---|---|
| $250M | $198M | $0.38 |
| $500M | $395M | $0.76 |
| $1,000M / $1.0B | $790M | $1.51 |
| $2,000M / $2.0B | $1,580M | $3.02 |
Interpretation: PFAS and CAE are largely accrued, but the upper end of PFAS ($12.5B PWS) and unquantified asbestos/Watson/Belgium matters mean reported EPS remains exposed to incremental charges. A $1B adverse pre-tax development would reduce EPS by roughly $1.51, all else equal.
Source: 10-K pp. 73–95; 10-Q pp. 19–41.
8. Related-Party Transactions
| Item | Amount / terms | Risk / opportunity |
|---|---|---|
| 3M policy statement | “3M does not have any material related party activity” | Low reported related-party risk |
| Solventum transition agreements | 2025 transition income ~$150M (gross fees ~$0.7B, net assigned costs); amounts due from Solventum ~$0.4B; due to Solventum ~$0.1B | Transition dependence; potential disputes; cash collection |
| Solventum supply/commercial agreements | Supply agreements reflected in net sales; transition income offsets SG&A | Ongoing commercial relationship |
| 3M India NCI | 75% effective ownership; NCI income $12M FY2025 | Minority interest leakage |
| Madison/Bain venture | 3M 50.1% voting; Bain contributed ~$1.3B; redeemable NCI $971M; put right in 5 years | Put/redemption risk; fire-safety growth opportunity |
Assessment: Reported related-party activity is not material under 3M’s Note 1 statement. The economically important related-party-like exposures are the Solventum transition/supply agreements and the Bain/Madison redeemable NCI. The Bain put right can create future cash redemption or derivative volatility.
Source: 10-K pp. 49–50; 10-Q pp. 8–9, 42–43.
9. Investments in Other Company Shares
| Investment | Position | Fair value / gain |
|---|---|---|
| Solventum common stock | ~15% ownership at Sep 30, 2026; current equity investment | Fair value $2.3B; unrealized gain $1.7B at Sep 30, 2026 |
| Solventum at Dec 31, 2025 | ~15% ownership | Fair value $2.0B; unrealized gain $1.5B |
| Marketable securities | Current $310M at Sep 30, 2026; $698M at Dec 31, 2025 | Liquidity portfolio |
| Unconsolidated subsidiaries | Income $52M FY2025; sold one investment for $47M pre-tax gain | Small earnings contribution |
Assessment: The Solventum stake is a meaningful non-operating asset (~$2.3B fair value) and a potential liquidity source, but it introduces mark-to-market EPS volatility. 3M intends to sell within five years of the 2024 spin-off, subject to restrictions.
Source: 10-K pp. 34, 72; 10-Q pp. 11, 53.
📊 Latest Equity Research & Market Insights
Apple Inc. (AAPL) — Comprehensive Multi‑Year Equity Research Report
Read Report →Microsoft Corporation (MSFT) — Investment Analysis Report
Read Report →NVIDIA Corporation (NVDA) — Integrated Equity Research Report
Read Report →Analog Devices (ADI) Stock Analysis: ADI FY2027 Forecast
Read Report →PALO ALTO NETWORKS, INC. (S&P500: PANW) — ANALYTICAL REPORT
Read Report →✅ S&P 500 Weekly Market Pulse (Oct 5–9, 2026)
Read Pulse →✅ NASDAQ 100 Weekly Market Pulse (Oct 5–9, 2026)
Read Pulse →10. Other Important Issues
- Leverage and equity: Total debt $14.997B vs total equity $4.169B at Sep 30, 2026; D/E 3.60x. Equity is low after buybacks and litigation charges.
Source: 10-Q p.5. - Debt maturity/credit ratings: Moody’s A3 stable; S&P BBB+ stable; Fitch A- stable. $4.25B revolver undrawn; EBITDA/interest covenant ≥3.0x; compliant.
Source: 10-K p.33; 10-Q p.52. - Dividend/buyback: 2026 dividend $0.78/qtr; $7.5B buyback authorization; $3.2B repurchased in 9M26; $1.5B remaining.
Source: 10-Q pp. 54, 56. - Pension: 98% funded worldwide; U.S. qualified 94% funded; 2026 expected contribution $100–$150M; 2026 U.S. expected return 8.0%.
Source: 10-K p.24, p.32. - Tax: Effective tax rate 23.8% FY2025 vs 16.7% FY2024; IRS examinations 2021–2023; gross UTB $516M.
Source: 10-K pp. 56–58. - Segment performance: Safety & Industrial is the largest and grew; Transportation & Electronics declined FY2025 but grew 9M26; Consumer was soft.
Source: 10-K pp. 25–27; 10-Q pp. 42–49. - Share count: Diluted shares 541.3M FY2025; 525.9M 9M26; buybacks reduce share count but also reduce equity.
Source: 10-K p.40; 10-Q p.3. - Dashboard-reported share count: 515,722,417 shares outstanding (dashboard, 2026-10-23), implying market cap of $89.46B at $173.46. This is slightly below the 9M26 10-Q shares outstanding of 516,729,574, consistent with continued buybacks.
Source: Dashboard (YFinance-derived); 10-Q p.5.
11. 9M 2026 Performance at a Glance
Basis: 9M 2026 vs 9M 2025 for income/cash-flow items. Balance-sheet items compare Sep 30, 2026 vs Dec 31, 2025 because the supplied 10-Q does not include a Sep 30, 2025 balance sheet.
| Metric | 9M 2026 | 9M 2025 | Change | Δ% |
|---|---|---|---|---|
| Revenue | $19,114M / $19.114B | $18,815M | +$299M | +1.6% |
| Gross profit | $7,922M / $7.922B | $7,899M | +$23M | +0.3% |
| Operating profit | $3,939M / $3.939B | $3,833M | +$106M | +2.8% |
| Net income attributable to 3M | $2,959M / $2.959B | $2,673M | +$286M | +10.7% |
| Diluted EPS | $5.63 | $4.93 | +$0.70 | +14.2% |
| NAVPS | $7.99 | NA* | NA* | NA* |
| Net CFO per diluted share | $3.89 | $1.33 | +$2.56 | +192% |
| Total assets | $39,526M / $39.526B | NA* | +$1,793M vs Dec25 | +4.8% vs Dec25 |
| Total equity | $4,169M / $4.169B | NA* | -$578M vs Dec25 | -12.2% vs Dec25 |
*NA = comparative Sep 30, 2025 balance sheet not included in supplied 10-Q. Use Dec 31, 2025 as the available comparative for total assets/equity.
Source: 10-Q pp. 3, 5, 6.
Dashboard-reported quarterly reconciliation (Q1–Q3 2026):
| Quarter | EPS (reported) | EPS growth YoY | Net income ($M) | NI growth YoY | Source |
|---|---|---|---|---|---|
| Q1 2026 | $1.23 | -40.00% | $653 | -41.49% | Dashboard (YFinance-derived) |
| Q2 2026 | $1.79 | +32.59% | $933 | +29.05% | Dashboard (YFinance-derived) |
| Q3 2026 | $2.65 | +69.87% | $1,373 | +64.63% | Dashboard (YFinance-derived) |
The dashboard’s quarterly EPS figures sum to $5.67, while the 10-Q reports 9M diluted EPS of $5.63; the difference is consistent with basic vs diluted share-count rounding and should not be read as a data error.
Source: 10-Q p.3; Dashboard (2026-10-23).
12. FY2026 Full-Year Forecast — Revenue, Net Income, EPS, Target Price
Important: These are illustrative projections, not company guidance. They use the Q3 2026 run-rate, 9M actuals, and the dashboard’s forward PE/PEG inputs. They exclude unknown future litigation charges, Solventum mark-to-market, and special items. The consensus-implied adjusted EPS from the dashboard’s forward PE is **$9.91** (price $173.46 ÷ forward PE 17.51x).
12.1 FY2026E Revenue
| Component | Amount | Basis / source |
|---|---|---|
| 9M 2026 actual revenue | $19,114M / $19.114B | 10-Q p.3 |
| Q4 2026E revenue | ~$6,550M / $6.55B | Q3 2026 actual $6,584M; Q4 seasonal/run-rate; 10-Q p.3 |
| FY2026E revenue | ~$25,664M / ~$25.66B | 9M actual + Q4E |
| YoY vs FY2025 $24,948M | +2.9% | 10-K p.40 |
12.2 FY2026E Net Income and EPS
| Metric | Q4 2026E | FY2026E | Basis / source |
|---|---|---|---|
| Net income attributable to 3M — GAAP | ~$1,280M / ~$1.28B | ~$4,239M / ~$4.24B | 9M actual $2,959M + Q4E; 10-Q p.3 |
| Net income YoY vs FY2025 $3,250M | — | +30.4% | 10-K p.40 |
| Diluted EPS — GAAP | ~$2.45 | ~$8.08 | 9M actual $5.63 + Q4E; 10-Q p.3 |
| Diluted EPS — adjusted (company-defined) | ~$2.50 | ~$9.61 | 9M adjusted $7.11 + Q4E; 10-Q p.50 |
| Consensus-implied adjusted EPS | — | ~$9.91 | Dashboard forward PE 17.51x at $173.46 (YFinance-derived) |
| Diluted shares | ~522.6M | ~522.6M | 9M 2026 diluted; 10-Q p.3 |
12.3 FY2026E Target Price
| Valuation anchor | Multiple / input | Implied price | Upside/(downside) vs $173.46 |
|---|---|---|---|
| Current forward PE | 17.51x × $9.91 | $173.46 | 0.0% |
| 18x FY2026E adjusted EPS | 18.0x × $9.91 | $178.38 | +2.8% |
| 20x FY2026E adjusted EPS | 20.0x × $9.91 | $198.20 | +14.3% |
| 22x FY2026E adjusted EPS | 22.0x × $9.91 | $218.02 | +25.7% |
| Trailing PE on FY2026E GAAP EPS | 25.89x × $8.08 | $209.19 | +20.6% |
| Sector PE on FY2026E adjusted EPS | 32.97x × $9.91 | $326.73 | +88.4% (sector premium scenario) |
Base-case target range: $178–$218, midpoint ~$198**, based on **18–22x FY2026E adjusted EPS of ~$9.91. The current price of $173.46 is approximately at the low end of this range and at the market’s current forward PE of 17.51x.
Source: Dashboard (2026-10-23, YFinance-derived forward PE and sector PE); 10-Q p.3, p.50; 10-K p.40.
12.4 Scenario matrix
| Scenario | Revenue | Net income (attributable) | GAAP EPS | Adjusted EPS | Target price (20x adj.) | Key assumption |
|---|---|---|---|---|---|---|
| Bear | $25.0B | $3.7B | $7.10 | $8.80 | $176.00 | Weaker Q4, tariff/FX headwinds, litigation charge |
| Base | $25.66B | $4.24B | $8.08 | $9.91 | $198.20 | Q3 run-rate sustained; no major new charges |
| Bull | $26.2B | $4.6B | $8.80 | $10.40 | $208.00 | Safety/electronics acceleration, margin recovery |
Source: Author projections anchored to 10-Q p.3, p.50; Dashboard forward PE (YFinance-derived).
13. Market Snapshot & Valuation Analytics
Source: Capital Insight BD “S&P 500 Stock Analysis Master Dashboard” for MMM, analysis period 2026-01-01 → 2026-10-23. Market and valuation metrics are YFinance/fundamental-feed derived. These are market data, not 10-K/10-Q figures.
13.1 Market snapshot (as of 2026-10-23)
| Metric | Value | Note |
|---|---|---|
| Current price | $173.46 | Date: 2026-10-23 |
| Period high | $184.90 | Date: 2026-07-28 |
| Period low | $139.34 | Date: 2026-03-20 |
| Period return | 7.19% | 2026-01-01 → 2026-10-23 |
| Annualized volatility | 27.18% | Period |
| Market cap | $89.46B | Dashboard |
| Average volume | 3,356,554 | Period |
| Trading days | 203 | Period |
| Shares outstanding | 515,722,417 | Dashboard company info |
| S&P 500 addition date | 1957-03-04 | Dashboard company info |
| CIK | 66740 | Dashboard company info |
| Fiscal year end | 12-31 | Dashboard company info |
13.2 Composite scores (0–100)
| Score | Value | Interpretation |
|---|---|---|
| Valuation score | 46.8 | Lower multiples → higher score; mid-range |
| Quality score | 45.9 | ROE/ROA/margins composite; mid-range |
| Growth score | 51.9 | EPS trend composite; slightly above mid-range |
| Composite score | 48.2 | Overall attractiveness; neutral-to-slightly-positive |
13.3 Valuation metrics
| Metric | Value | Percentile / note |
|---|---|---|
| PE (trailing) | 25.89x | 34.3rd percentile; hist. avg. 27.52x |
| Forward PE | 17.51x | Implies ~$9.91 forward EPS |
| PEG | 1.57 | “Fairly valued” per dashboard |
| PB | 21.72x | High vs sector 8.64x |
| PS | 3.54x | Slightly below sector 3.75x |
| EV/EBITDA | 15.21x | — |
| EV/Revenue | 3.92x | — |
| PE mean (history) | 27.52x | 204 observations |
| PE median | 28.01x | — |
| PE std dev | 2.98x | — |
| PE min / max | 22.72x / 34.01x | — |
| PE volatility (ann.) | 38.09% | — |
| PE max drawdown | -23.87% | — |
13.4 Profitability and growth (dashboard)
| Metric | Value | Trend |
|---|---|---|
| ROE | 72.97% | ▲ 19.21% |
| ROA | 8.22% | ▼ -0.44% |
| ROIC | 32.57% | ▼ -0.56% |
| Gross margin | 39.53% | ▼ -0.63% |
| Operating margin | 23.69% | ▲ 0.02% |
| Latest annual EPS | $6.05 (FY2025) | -20.18% YoY |
| EPS CAGR (5y) | -8.49% | 2020-12-31 → 2025-12-31 |
| Latest annual net income | $3,250M (FY2025) | — |
| Latest reported EPS | $2.65 (Q3 2026) | +69.87% YoY |
| Latest reported net income | $1,373M (Q3 2026) | — |
Note: The dashboard’s FY2025 EPS of $6.05 is close to the 10-K’s diluted EPS of $6.00; the small difference is consistent with rounding/basic-vs-diluted differences. The dashboard’s Q3 2026 EPS of $2.65 matches the 10-Q diluted EPS of $2.63 within rounding.
Source: Dashboard (2026-10-23, YFinance/fundamental-feed derived); 10-K p.40; 10-Q p.3.
14. Sector Comparison & Profitability Benchmarks (Dashboard Data)
Peer set: Industrials, 83 peers. Source: Capital Insight BD Dashboard (2026-10-23, YFinance-derived).
| Metric | 3M (MMM) | Industrials sector avg | Delta | Interpretation |
|---|---|---|---|---|
| PE ratio | 25.89x | 32.97x | -21.47% | 3M trades at a discount to sector PE |
| PB ratio | 21.72x | 8.64x | +151.28% | 3M trades at a large premium on book value |
| PS ratio | 3.54x | 3.75x | -5.39% | Slight discount on sales |
| ROE | 72.97% | 31.25% | +133.47% | Much higher ROE, but flattered by low equity |
| ROA | 8.22% | 8.34% | -1.38% | Roughly in line |
| ROIC | 32.57% | 18.70% | +74.21% | Strong capital efficiency vs sector |
| Gross margin | 39.53% | 35.54% | +11.23% | Above sector |
| Operating margin | 23.69% | 18.23% | +29.93% | Above sector |
Interpretation: 3M screens as a higher-margin, higher-ROIC, lower-PE Industrials name relative to its sector, but its PB premium reflects a very small book-equity base after buybacks and litigation charges, not necessarily a richer asset-based valuation. The sector comparison is a market-based peer read, not a U.S. industry-average accounting ratio set.
Source: Dashboard (2026-10-23, YFinance-derived).
15. Stock Performance vs S&P 500, Volatility & Risk (Dashboard Data)
Source: Capital Insight BD Dashboard (2026-10-23, YFinance-derived), analysis period 2026-01-01 → 2026-10-23.
| Metric | MMM | S&P 500 | Delta / note |
|---|---|---|---|
| Total return | 7.19% | 11.16% | -3.97 pp underperformance |
| Annualized return | 9.01% | 13.96% | -4.95 pp |
| Volatility (annualized) | 27.11% | 12.93% | ~2.1x index volatility |
| Correlation with S&P 500 | 0.336 | 1.000 | Low-to-moderate correlation |
| Daily win rate | 49.75% | — | Slightly below 50% |
15.1 Yearly monthly high/low summary (dashboard)
| Year | Lowest avg month | Lowest avg price | Month-end price | Highest avg month | Highest avg price | Month-end price |
|---|---|---|---|---|---|---|
| 2024 | February | $73.20 | $73.24 | October | $128.78 | $125.96 |
| 2025 | April | $134.28 | $137.60 | November | $167.15 | $172.05 |
| 2026 | May | $147.82 | $153.13 | August | $180.04 | $171.83 |
Interpretation: 3M’s 2026 YTD return of 7.19% lagged the S&P 500’s 11.16%, with materially higher volatility (27.11% vs 12.93%) and low correlation (0.336). The stock’s 2026 trading range has been roughly $139.34–$184.90, with the period low in March and the period high in July. This is consistent with a litigation-overhang, special-items-driven equity rather than a pure macro beta play.
Source: Dashboard (2026-10-23, YFinance-derived).
16. Ownership Structure & Insider Activity (Dashboard Data)
Source: Capital Insight BD Dashboard, ownership as of 2026-09-30 (YFinance/institutional-filing derived).
16.1 Ownership summary by category
| Category | Shares | Value | % Held |
|---|---|---|---|
| Institutional | 199,639,986 | $31,934,413,496 | 38.71% |
| Mutual fund | 73,275,822 | $11,721,200,974 | 14.21% |
| Insider | 420,697 | $0 | 0.08% |
16.2 Top 10 institutional holders
| Holder | Shares | Value | % Held |
|---|---|---|---|
| BlackRock Inc. | 45,048,766 | $7,206,000,911 | 8.74% |
| JPMorgan Chase & Co | 39,432,727 | $6,307,659,275 | 7.65% |
| Vanguard Capital Management LLC | 34,065,039 | $5,449,043,867 | 6.61% |
| State Street Corporation | 27,828,966 | $4,451,521,588 | 5.40% |
| Geode Capital Management, LLC | 11,957,078 | $1,912,654,277 | 2.32% |
| Vanguard Portfolio Management LLC | 9,542,983 | $1,526,495,624 | 1.85% |
| Capital World Investors | 8,392,028 | $1,342,388,855 | 1.63% |
| State Farm Mutual Automobile Insurance Co | 7,934,035 | $1,269,128,291 | 1.54% |
| Norges Bank | 7,808,095 | $1,248,982,928 | 1.51% |
| Morgan Stanley | 7,630,269 | $1,220,537,880 | 1.48% |
16.3 Top mutual fund holders
| Holder | Shares | Value | % Held |
|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 16,558,288 | $2,648,663,859 | 3.21% |
| Vanguard 500 Index Fund | 13,514,795 | $2,161,826,698 | 2.62% |
| iShares Core S&P 500 ETF | 6,945,335 | $1,110,975,833 | 1.35% |
| Fidelity 500 Index Fund | 6,770,408 | $1,082,994,509 | 1.31% |
| SPDR S&P 500 ETF Trust | 6,388,189 | $1,021,854,755 | 1.24% |
| SPDR Dow Jones Industrial Average ETF | 5,084,125 | $813,256,669 | 0.99% |
| Vanguard Value Index Fund | 4,966,521 | $794,444,732 | 0.96% |
| JPMorgan Large Cap Growth Fund | 4,751,099 | $759,985,827 | 0.92% |
| Washington Mutual Investors Fund | 4,377,100 | $700,160,945 | 0.85% |
| JPMorgan Equity Premium Income ETF | 3,919,962 | $627,037,147 | 0.76% |
16.4 Top insider holders
| Holder | Shares | % Held |
|---|---|---|
| Roman Michael F | 192,408 | 0.04% |
| Banovetz John Patrick | 50,056 | 0.01% |
| Rhodes Kevin H | 43,780 | 0.01% |
| Murphy Mark W | 22,872 | 0.00% |
| Dickson Zoe L | 21,832 | 0.00% |
| Fitterling James R | 19,480 | 0.00% |
| Page Gregory R | 19,480 | 0.00% |
| Brown Thomas K | 18,980 | 0.00% |
| Chavez Rodriguez Beatriz Karina | 16,244 | 0.00% |
| Dillon David B | 15,565 | 0.00% |
Interpretation: 3M is overwhelmingly institutionally and index-fund owned (institutional 38.71%, mutual funds 14.21%), with insider ownership very low (0.08%). BlackRock, JPMorgan, Vanguard, and State Street together hold a large block. This ownership structure is typical of a mature S&P 500 constituent and implies that index flows and large institutional positioning can dominate short-term price behavior.
Source: Dashboard (2026-09-30 ownership data, YFinance/institutional-filing derived).
17. Data Sources & Methodology
| Data category | Source | Notes |
|---|---|---|
| FY2025 income statement, balance sheet, cash flow, notes, legal proceedings, risk factors | 3M Form 10-K for FY2025 (attached) | Primary SEC filing; page references in Section 18 |
| Q3/9M 2026 income statement, balance sheet, cash flow, notes, legal proceedings | 3M Form 10-Q for Q3 2026 (attached) | Primary SEC filing; page references in Section 18 |
| Market price, market cap, shares outstanding, period high/low, returns, volatility, volume | Capital Insight BD Dashboard, MMM, 2026-01-01 → 2026-10-23 | YFinance/market-data feed derived |
| Trailing PE, forward PE, PEG, PB, PS, EV/EBITDA, EV/Revenue, PE percentile/history | Capital Insight BD Dashboard | YFinance/fundamental-feed derived; forward PE and PEG are consensus/valuation-feed estimates |
| Composite scores (valuation, quality, growth, overall) | Capital Insight BD Dashboard | Proprietary normalization of valuation, profitability, growth |
| Sector comparison (Industrials, 83 peers) | Capital Insight BD Dashboard | YFinance/sector-peer derived |
| Stock performance vs S&P 500, correlation, win rate, yearly high/low | Capital Insight BD Dashboard | YFinance/market-data feed derived |
| Ownership (institutional, mutual fund, insider; top holders) | Capital Insight BD Dashboard, as of 2026-09-30 | Institutional-filing/YFinance derived |
| Company profile (CIK, S&P 500 addition, fiscal year end) | Capital Insight BD Dashboard | Company/reference data |
| Author projections, what-if EPS, target price scenarios | Author calculations | Explicit assumptions stated; not company guidance |
| U.S. industry-average accounting ratios | Not available in attached filings | Marked NA; do not treat as verified industry averages |
Methodology notes:
- FY2025 and 9M 2026 statement figures are taken directly from the attached 10-K/10-Q and are not adjusted unless stated.
- Δ% is calculated as (current − prior) ÷ prior; for expense/liability lines, a positive change is an increase in the absolute amount.
- Turnover ratios use ending balances for FY2025/FY2024 comparability; 9M 2026 uses 273 days.
- EBITDA is author-calculated as operating income + D&A; it is not a GAAP measure.
- Market-based ratios and composite scores are from the dashboard and are not extracted from the 10-K/10-Q. They should be read as market/valuation analytics, not audited financial statements.
- Forward PE, PEG, and related consensus-style inputs are YFinance/valuation-feed derived and can change with price and estimate revisions.
18. Disclaimer
This report is for information and educational purposes only. It is not investment advice, a recommendation, or an offer to buy or sell securities. Projections, target prices, and what-if analyses are illustrative and based on stated assumptions; actual results may differ materially. The author relied on the attached 3M 10-K and 10-Q for financial-statement and legal-proceeding data and on the Capital Insight BD dashboard (YFinance/fundamental-feed derived) for market, valuation, sector-comparison, performance, and ownership data. The author has not independently verified every figure in the dashboard feed. U.S. industry-average accounting ratios were not available in the attached filings and are intentionally not fabricated. Readers should consult the original SEC filings and a licensed financial adviser before making investment decisions.
Md Kollol Hossain
CEO, CapitalinsightBD
info@capitalinsightbd.com